latest news in investor rights

DexCom Faces Legal Deadline Amid Investor Lawsuit Over Misleading Device Claims

New York, Saturday, 6 December 2025.
DexCom investors must act by December 26, 2025, to join a class action lawsuit alleging misleading statements about G6 and G7 devices, impacting reliability and safety, leading to significant losses.

Tandem Diabetes Care Faces Legal Scrutiny Amid Stock Drop

New York, Sunday, 30 November 2025.
The Rosen Law Firm is investigating Tandem Diabetes Care for potential securities violations. Investor losses spiked after an insulin pump issue led to a 19.9% stock decline.